"10.1371_journal.pone.0074188","plos one","2013-09-20T00:00:00Z","Kooresh I Shoghi; Jinbin Xu; Yi Su; June He; Douglas Rowland; Ying Yan; Joel R Garbow; Zhude Tu; Lynne A Jones; Ryuji Higashikubo; Kenneth T Wheeler; Ronald A Lubet; Robert H Mach; Ming You","Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, United States of America; Department of Biomedical Engineering, Washington University School of Medicine, St. Louis, Missouri, United States of America; Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, United States of America; Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri, United States of America; Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri, United States of America; Division of Biology and Biomedical Sciences, Washington University School of Medicine, St. Louis, Missouri, United States of America; Center for Molecular and Genomic Imaging, University of California Davis, Davis, California, United States of America; Department of Radiology, Wake Forest University Health Science Center, Winston-Salem, North Carolina, United States of America; National Institutes of Health, Bethesda, Maryland, United States of America; Cancer Center and Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America","Conceived and designed the experiments: KIS JX JH DR JRG LAJ RAL KTW RHM MY. Performed the experiments: JX JH DR YY RH LAJ. Analyzed the data: KIS JX YS JH DR YY LAJ. Contributed reagents/materials/analysis tools: ZT. Wrote the paper: KIS JX JRG LAJ RHM MY.","Drs. Robert Mach and Zhude Tu have a patent relating to the compound used in this work. The patent title is Radiolabelled benzamide analogues, their synthesis and use in diagnostic imaging (patent # US 7,659,400 B2) awarded February 9, 2010. Isotrace Technologies, LLC, St. Charles, Missouri, has a licensing agreement with Washington University School of Medicine for the commercialization of 18F-labeled sigma-2 receptor radiotracers developed in the laboratory of Dr. R.H. Mach. Dr. Mach and Dr. Tu have no financial interests in Isotrace Technologies, nor are they paid consultants for the company. The patent does not alter the authors adherence to the PLOS ONE policies on sharing data and materials.","2013","09","Kooresh I Shoghi","KIS",14,TRUE,10,6,7,6,TRUE,TRUE,FALSE,0,NA,FALSE
